The Effect of Auricular Acupressure on the Improvement of Anxiousness, Depression and Heart Rate Variability in Stroke Patients
Cathay General Hospital
1 other identifier
interventional
70
1 country
1
Brief Summary
Heart rate variability (HRV) in post-stroke patients are closely related to patient mortality, neurological deterioration and overall prognosis. Anxiety and depression will demotivate the patients' will to undergo rehabilitation program, which would delay their functional recovery. The influence of acupressure over the auricle on the HRV, anxiousness and depressive mood have yet to be verified. The investigators aimed to study the effect on auricular acupressure treatment between the different trending of HRV, anxiety and depression and their correlations. This is a randomized control study, consisted of 70 patients with post-stroke depressive mood, from both CGH and Xizhi Cathay hospital in Taiwan. HRV analysis is performed on the first 24 hours, and on a weekly basis for a total of 6 weeks. The included depressed patients were defined by the "Hospital Anxiety and Depression Scale" and weekly will be undertaken by the patients. A "Taiwanese Depression Questionnaire" pre-test and after-test will be undertaken by the patients. Experimental group will receive acupressure treatment by the second week, trice daily, 3\~5minutes each session for a course of four weeks. Data were analyzed using SPSS 20.0, using generalized estimating equation, GEE. The study hypothesized that the auricular acupressure treatment would improve post-stroke depression. Therefore, participants would be more willing to receive rehabilitation program. Our study would also help to provide future references on related studies.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started May 2021
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 14, 2021
CompletedFirst Submitted
Initial submission to the registry
January 26, 2022
CompletedFirst Posted
Study publicly available on registry
February 16, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 13, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
August 13, 2022
CompletedFebruary 16, 2022
February 1, 2022
12 months
January 26, 2022
February 5, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Taiwanese Depression Questionnaire
The Taiwanese Depression Questionnaire(TDQ), which is a 4-point scale with 18 items, is a culturally specific depression self-rating instrument for effective screening of depression in Taiwan and has satisfactory reliability and validity. Subjects are guided to rate each item on a scale from 0 to 3 on the basis of "how often you felt the physical and emotional aspects during the past week". TDQ scores range from 0 to 54. The original test authors defined three ranges for both of the scales: 0-13 (non-cases), 14-18 (doubtful cases), and 19-54(cases). The higher the score, the more severe the depression.The Taiwanese Depression Questionnaire(TDQ) had a sensitivity of 0.89 and a specificity of 0.92 .
4 Weeks
Hospital Anxiety and Depression Scale
The reliability of the HADS was good, with Cronbach's α coefficients of 0.86 (anxiety), 0.85 (depression), and 0.91 (total scale).The HADS consists of 14 items. Seven of the items indicate anxiety and the remaining seven items indicate depression. Each item had been answered by the patient on a four point (0-3) response category so the possible scores ranged from 0 to 21 for anxiety and 0 to 21 for depression. The original test authors defined three ranges for both of the scales: 0-7 (non-cases), 8-10 (doubtful cases), and 11-21(cases). It is possible to calculate a HADS total score by simply summing up the anxiety and depression items.
4 Weeks
Secondary Outcomes (1)
Heart rate variability (HRV)
4 weeks
Study Arms (2)
Experimental group
EXPERIMENTALExperimental group will receive acupressure treatment by the second week, trice daily, 3\~5minutes each session for a course of four weeks.
Control group
NO INTERVENTIONExperimental group will receive routine care for a course of four weeks.
Interventions
Auricular therapy, as defined by Oleson, refers to "a healthcare modality by stimulating the external surface of the ear to alleviate pathological conditions in other parts of the body"Experimental group will receive acupressure treatment by the second week, trice daily, 3\~5minutes each session for a course of four weeks
Eligibility Criteria
You may qualify if:
- over 20 years old
- Within 24 hours of arriving at the hospital with the first symptoms of stroke
- Hemorrhagic stroke:nontraumatic hemorrhagic stroke and Intracerebral Hemorrhage score 0-1
- Infarct stroke:National Institutes of Health Stroke Scale less than 30
- Able to express themselves through oral or written communication
- Hospital Anxiety and Depression Scale Score equal to or greater than 11
You may not qualify if:
- Previous diagnosis of arrhythmia
- Mental illness, dementia, Alzheimer's disease, or possible complete paralysis on imaging
- Subarachnoid hemorrhage, subdural hemorrhage, epidural hemorrhage
- Patients with acute myocardial infarction
- There is a wound or lesion at the ear auricular point
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Cathay General Hospital
Taipei, 106, Taiwan
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
January 26, 2022
First Posted
February 16, 2022
Study Start
May 14, 2021
Primary Completion
May 13, 2022
Study Completion
August 13, 2022
Last Updated
February 16, 2022
Record last verified: 2022-02